{
  "id": 8962835,
  "title": "Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production",
  "url": "https://urgent.news/2026/09/21/eli-lilly-ceo-tells-cnbc-one-third-of-new-glp-1-pill-patients-are",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-21T17:06:10.000Z",
  "source": {
    "name": "CNBC",
    "slug": "cnbc",
    "url": "https://www.cnbc.com/2026/09/21/lilly-is-ramping-up-future-manufacturing-for-foundayo-obesity-pill.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "Eli Lilly is trying to catch up in the GLP-1 pill market to Novo, which got a head start in the space.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}